Here is the synopsis of our sample research paper on Non-Hodgkin's Lymphoma. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 3 page research paper that discusses treatment options and possible outcomes for non-Hodgkin's lymphoma patients. Bibliography lists 4 sources.
Page Count:
3 pages (~225 words per page)
File: KL9_khnhl.doc
Buy This Term Paper »
Unformatted sample text from the term paper:
Hispanic female with stage IV NHL. This analysis will specifically focus how this care compares to the standards indicated in literature. This writer/tutor cannot reasonably comment on the diagnostic
phase of treatment as this aspect of care was not included in the information faxed by the student. However, the student may choose to write in her own paper that
when the patient was admitted on December 24, 2011, her medical history indicated stage IV NHL and also that she has been undergoing chemotherapy for the last six months, with
recurring episodes of pancytopenia, and multiple infections (sepsis, urinary tract). In January, the patient developed a left-sided pleural effusion, which has not been completely resolved by antibiotics. Treatment The
gold standard for treating patients with aggressive NHL in its advanced stages is to use chemotherapy either as a single option or in combination with local-field radiation therapy ("Adult
NHL," 2011). The long-term survival rate for patients on doxorubicin-based combination chemotherapy is between 35 and 45 percent, when used along or in combination with radiation therapy ("Adult NHL," 2011).
It has been shown that a combination of rituximab and CHOP (cyclophosphamide plus doxorubicin plus vincristine plus prednisone)(known as R-CHOP) has been shown to promote event-free survival when compared to
using CHOP alone. This study involved 399 patients who were 60 years of age and older in the advanced stages of NHL ("Adult NHL," 2011). Rituximab (Rituxan) is a
"type of monoclonal antibody that attaches to B cells and makes them more visible to the immune system" (Mayo Clinic, 2012). As this indicates this drug is designed to aid
the immune system in fighting the cancer. Additionally, a preliminary study that involved using CHOP with and without etoposide in regards to older adult NHL patients found improvement when treatment
...